JP2012505665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012505665A5 JP2012505665A5 JP2011532316A JP2011532316A JP2012505665A5 JP 2012505665 A5 JP2012505665 A5 JP 2012505665A5 JP 2011532316 A JP2011532316 A JP 2011532316A JP 2011532316 A JP2011532316 A JP 2011532316A JP 2012505665 A5 JP2012505665 A5 JP 2012505665A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- population
- solution
- adipose tissue
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10635308P | 2008-10-17 | 2008-10-17 | |
| US61/106,353 | 2008-10-17 | ||
| PCT/US2009/061185 WO2010045645A1 (en) | 2008-10-17 | 2009-10-19 | Methods of obtaining cell populations from adipose tissue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012505665A JP2012505665A (ja) | 2012-03-08 |
| JP2012505665A5 true JP2012505665A5 (enExample) | 2012-12-06 |
Family
ID=41381576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011532316A Pending JP2012505665A (ja) | 2008-10-17 | 2009-10-19 | 脂肪組織から細胞集団を得る方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110274667A1 (enExample) |
| EP (1) | EP2356214A1 (enExample) |
| JP (1) | JP2012505665A (enExample) |
| CN (1) | CN102186968A (enExample) |
| AU (1) | AU2009305532A1 (enExample) |
| CA (1) | CA2740578A1 (enExample) |
| WO (1) | WO2010045645A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9234897B2 (en) * | 2005-03-31 | 2016-01-12 | Two Cells Co., Ltd | Method for distinguishing mesenchymal stem cell using molecular marker and use thereof |
| WO2013126590A2 (en) | 2012-02-21 | 2013-08-29 | Baxter International Inc. | Pharmaceutical composition comprising cd34+ cells |
| WO2014089554A1 (en) * | 2012-12-07 | 2014-06-12 | Antria, Inc. | Formulations containing and kit for using adipose-derived stem cells and use thereof |
| JP2016017068A (ja) * | 2014-07-10 | 2016-02-01 | 国立大学法人金沢大学 | 脂肪組織由来間質細胞群を含む消化管炎症治療剤 |
| FR3024778B1 (fr) * | 2014-08-05 | 2021-01-22 | Screencell | Procede pour le depistage de la drepanocytose et kit pour sa mise en oeuvre |
| EP3360957A4 (en) * | 2015-10-08 | 2019-03-13 | Kaohsiung Medical University | COMPOSITION FOR THE QUICK SEPARATION OF CELLS FROM FAT |
| WO2017141831A1 (ja) * | 2016-02-16 | 2017-08-24 | ロート製薬株式会社 | 脂肪組織由来間質細胞を含む虚血性疾患治療剤およびその製造方法 |
| US12161688B2 (en) | 2016-06-30 | 2024-12-10 | Mapi Pharma Ltd | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
| CN106337036A (zh) * | 2016-08-26 | 2017-01-18 | 杭州易文赛生物技术有限公司 | 一种提高脂肪组织中cd34阳性血管基质成分提取率的方法 |
| CN106399234A (zh) * | 2016-08-31 | 2017-02-15 | 肖锷 | 脂肪组织的处理方法及间充质干细胞、处理后单个脂肪细胞和细胞外基质 |
| CA3062123A1 (en) | 2017-05-15 | 2018-11-22 | Stem Cell Medicine Ltd. | Treatment of multiple sclerosis with adipose-derived stem cells |
| CN110709091A (zh) | 2017-05-15 | 2020-01-17 | 干细胞医药有限公司 | 使用长效格拉替雷和脂肪源性干细胞治疗多发性硬化症 |
| CN108261424B (zh) * | 2018-01-24 | 2020-11-06 | 中国医学科学院医药生物技术研究所 | 一种肝癌的生物治疗方法 |
| US20210369608A1 (en) * | 2018-02-23 | 2021-12-02 | Regeneration Biomedical, Inc. | Methods, apparatuses and systems for instilling stem cells and pharmaceuticals into the human ventricular system |
| CN111518761B (zh) * | 2020-05-25 | 2022-04-29 | 青岛瑞思德生物科技有限公司 | 一种间充质干细胞体外筛选、激活、扩增、冻存及其细胞库建立的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4808532A (en) * | 1985-07-01 | 1989-02-28 | The United States Of America As Represented By The United States Department Of Energy | Continuous human cell lines and method of making same |
| US5968753A (en) * | 1994-06-14 | 1999-10-19 | Nexell Therapeutics, Inc. | Positive and positive/negative cell selection mediated by peptide release |
| EP1859025A4 (en) * | 2005-01-31 | 2009-07-22 | Cognate Therapeutics Inc | PROPERTIES OF ENDOTHELIAL CELLS DISPLAYING ADAS (ADIPOSED DERIVED ADULT STROMAL) CELLS |
| WO2007103379A2 (en) * | 2006-03-07 | 2007-09-13 | Humacyte | Method for endothelial cell extraction from adipose tissues |
-
2009
- 2009-10-19 WO PCT/US2009/061185 patent/WO2010045645A1/en not_active Ceased
- 2009-10-19 JP JP2011532316A patent/JP2012505665A/ja active Pending
- 2009-10-19 CA CA2740578A patent/CA2740578A1/en not_active Abandoned
- 2009-10-19 US US13/124,632 patent/US20110274667A1/en not_active Abandoned
- 2009-10-19 EP EP09741541A patent/EP2356214A1/en not_active Withdrawn
- 2009-10-19 AU AU2009305532A patent/AU2009305532A1/en not_active Abandoned
- 2009-10-19 CN CN200980141395.4A patent/CN102186968A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012505665A5 (enExample) | ||
| US11173182B1 (en) | Placenta-derived adherent cell exosomes and uses thereof | |
| Zhao et al. | Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics | |
| EP0136353B1 (fr) | Milieu de culture de cellules animales sans serum et procedes de culture primaire et d'obtention de lignees cellulaires utilisant ce milieu | |
| CN103648509B (zh) | 与间充质干细胞外来体相关的方法和组合物 | |
| KR20180114073A (ko) | 향상된 성체 간 전구 세포 제제 | |
| JP2009536163A (ja) | 免疫学的寛容および調節性前駆細胞 | |
| EP2972368A2 (en) | Lymphocyte biomarkers for determining the clinical response to cell therapy | |
| EP4556072A2 (en) | Compositions for monocyte and macrophage polarization and methods of use | |
| Cao et al. | Culture and properties of adipose-derived mesenchymal stem cells: characteristics in vitro and immunosuppression in vivo | |
| JP2021118728A (ja) | 線維芽細胞の製造方法及びｇ−ｃｓｆ陽性線維芽細胞集団 | |
| CN110403959B (zh) | 间充质干细胞外泌体制剂及其应用 | |
| Zhang et al. | Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency | |
| CN110982776A (zh) | 肝细胞的体外扩增培养方法及应用 | |
| Cheng et al. | Nanomaterial‐mediated reprogramming of macrophages to inhibit refractory muscle fibrosis | |
| EP4098267A1 (en) | Medicinal composition comprising dental pulp-derived cells | |
| CN115361958A (zh) | 使用间充质谱系前体或干细胞治疗炎症性肺病的方法 | |
| CN103237887A (zh) | 胚胎干细胞来源的心肌细胞以及包含所述心肌细胞作为活性成分的细胞治疗剂 | |
| CN113518624A (zh) | 用于选择性体内扩增γδT细胞群的方法及其组合物 | |
| WO2005024004A1 (ja) | 間葉系幹細胞の肝細胞への分化方法及び人工ヒト肝臓細胞 | |
| JP6076076B2 (ja) | 組織再生促進剤 | |
| WO2022046954A1 (en) | Appl cells improved placental-derived adherent cells and methods of their use | |
| TWI752077B (zh) | 肝臟組織再生用組成物 | |
| Deng et al. | Molten‐Salt‐Mediated Synthesis of Atomic Manganese/Cobalt Catalysts on Bioceramic Microparticles for Catalytic Anti‐Osteoarthritis Treatments | |
| KR102549781B1 (ko) | 간 조직 재생용 조성물 |